Skip to main content
OpenTrials
Completed

NCT Number: NCT00486993

Cardiovascular Risk Factors in an Ambulatory Urban Patient Population

According to WHO estimations, cardiovascular diseases (CVDs) are the number one cause of death globally. More people die annually from CVDs than from any other cause. An estimated 17.5 million people died from CVDs in 2005, representing 30% of all global deaths. Of these deaths, an estimated 7.6 million were due to coronary heart disease and 5.7 million were due to stroke.

Over 80% of CVD deaths take place in low- and middle-income countries and occur almost equally in men and women. In Paraguay, prevalence of classic risk factors, as well as new ones, like the metabolic syndrome are not completely known.

Government health policies in industrialized countries are focusing on programs to modify cardiovascular risk factors. In developing countries, prevention of coronary heart disease and stroke through modification of cardiovascular risk factors are not playing a large role at the moment.

The aim of this study is to define the effects of changes in lifestyle on cardiovascular risk factors, when added to optimized standard pharmacological therapy for arterial hypertension, diabetes mellitus and hyperlipidemia, in an ambulatory urban patient population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Risk Factors Arterial Occlusive Diseases Arteriosclerosis Behavior Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Coronary Artery Disease Coronary Disease Glucose Metabolism Disorders Heart Diseases Hyperinsulinism Insulin Resistance Lifestyle Modification Metabolic Diseases Metabolic Syndrome Motor Activity Myocardial Ischemia Nervous System Diseases Nutritional and Metabolic Diseases Smoking Stroke Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Central Instituto de Prevision Social

Asunción, Dep. Central, 1749, Paraguay

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all ambulatory patients, with age 18 years or older

Exclusion criteria

  • no exclusion criteria provided, particularly for the first, epidemiological part of the study

Treatment and study plan

Dietary and nutritional modification

Behavioral

Stop smoking

Behavioral

Regular physical activities

Behavioral

Weight reduction to normal ranges

Behavioral

Regular intake of polyphenols, esp. from Ilex paraguayensis

Behavioral

Primary outcomes

  1. cardiovascular mortality

    Time frame: one year

Secondary outcomes

  1. mortality, other causes

    Time frame: one year

  2. acute myocardial infarction

    Time frame: one year

  3. stroke

    Time frame: one year

  4. acute coronary syndrome

    Time frame: one year

Sponsors and collaborators

Lead sponsor

Heidelberg University

Other

Registry information

Official study title

Estimation of Prevalence and Assessment of the Effects of Modification of Cardiovascular Risk Factors in an Ambulatory Urban Patient Population

Acronym: AsuRiesgo

Important dates

Study start
2006
Primary completion
2014
Study completion
2014
First posted
Jun 15, 2007
Registry last updated
Nov 8, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.